Palliative Care Market Size, Share, Growth Analysis, By Condition(Cancer, Dementia, HIV, Cerebrovascular Disease), By Diagnostics(Communicable diseases, Non-Communicable diseases, Injury, poisoning), By Service Type(Private Residence Care, Hospice Inpatient Care, Hospital Inpatient Care, Nursing Home and Residential Facility Care), By Age Group(Pediatric, Adult, Geriatric), By End User(Hospitals, Home Care Settings, Palliative Care Centre, Long-Term Care Centre & Rehabilitation Centre), By Age Group(Pediatric, Adult, Geriatric), By End User(Hospitals, Home Care Settings, Palliative Care Centre, Long-Term Care Centre & Rehabilitation Centre), By Region - Industry Forecast 2025-2032

Palliative Care Market Drivers

Increasing number of palliative care facilities worldwide

• As the world's population ages and the number of people suffering from life-threatening illnesses increases in both industrialized and developing countries, the need for palliative care is increasing globally. According to WHO, only about 14% of people who need palliative care currently receive it around the world. As a result, these facilities are increasing globally. Over the past ten years, it has expanded rapidly and steadily throughout the world. Adults who require this care have chronic diseases such as cancer (34%), cardiovascular disease (38.5%), chronic respiratory disease (10.3%), AIDS (5.7%), and diabetes (4.6%). According to the Center for Advanced Palliative Care, approximately 61% of all hospitals with 50 or more beds in the US have a palliative care team. The increasing number of these centers worldwide is driving the global market.

Palliative Care Market Restraints

Palliative care services are not readily available in emerging and poor nations

• WHO claims that stringent rules governing morphine and other necessary regulated palliative medications prevent patients from receiving proper care. Around 40 million individuals need palliative care annually, with 78% of them residing in low- and middle-income nations. The global market is constrained by the lack of access to these services in developing and impoverished nations. Essential medications, such as morphine for pain relief, are inaccessible in developing nations. These nations either do not provide any services or provide those services only toward the end of the disease for those with chronic, life-threatening illnesses. Lack of public awareness, inadequate training in palliative care for medical staff and volunteers, exclusion from national policies, and limited partnership working affect the market in such countries.